11/6
08:31 am
dnth
Rating for DNTH
Medium
Report
Rating for DNTH
11/6
08:31 am
dnth
Rating for DNTH
Medium
Report
Rating for DNTH
9/12
10:29 am
dnth
Rating for DNTH
Low
Report
Rating for DNTH
9/12
08:08 am
dnth
Rating for DNTH
Low
Report
Rating for DNTH
9/12
08:08 am
dnth
Rating for DNTH
Low
Report
Rating for DNTH
9/9
11:21 am
dnth
Dianthus Therapeutics (NASDAQ:DNTH) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $63.00 price target on the stock, up previously from $56.00.
Medium
Report
Dianthus Therapeutics (NASDAQ:DNTH) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $63.00 price target on the stock, up previously from $56.00.
9/9
11:07 am
dnth
Rating for DNTH
Medium
Report
Rating for DNTH
9/9
11:07 am
dnth
Rating for DNTH
Medium
Report
Rating for DNTH
9/9
09:00 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
9/9
09:00 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
9/9
07:38 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
9/9
07:38 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
9/8
08:46 am
dnth
Dianthus Therapeutics (NASDAQ:DNTH) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
High
Report
Dianthus Therapeutics (NASDAQ:DNTH) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.